Cadila: COVID vaccine to be the key differentiator in the near term Trading Calls - Equity F&O February 9, 2021Recommendations In the next fiscal, Cadila plans to launch 40-plus products, including 8-10 complex molecules which should offset pricing erosion Anubhav Sahu
